Dapaglifozin,Teneligliptin,Vildagliptin,Linaglipti

Product Details:

Dapaglifozin 10 & Metformin 500mg Tablets.

• Exerts antihyperglycaemic, cardioprotective & renoprotective properties
• Reduces renal glucose reabsorption by increasing urinary glucose excertion & reducing blood glucose levels

Product Details:

Linagliptin 5 Mg Tablets

• Provide a valuable treatment option for individuals with inadequate glycaemic control
• Internationally approved & accepted

Product Details:

Dapagliflozin 10mg Sitagliptin 100mg & Metformin 500mg Tablets

• Well tolerated & improved glycaemic control
• Exerts antihyperglycaemic cardioprotective & renoprotective properties
• Improves lipid profile of body by reducing hypertriglyceridemia

Product Details:

Vildagliptin 50 mg  Tablets 

• Improves glucose control and significantly reduces GI adverse events.
• Improved glycemic control and was highly tolerable in T2DM patients
  
   

Product Details:

Glimepiride 2 mg Metformin 1000 mg SR tablets.

• Corrects defective insulin secretion & peripheral insulin resistance
• Decreases fasting & pp plasma insulin & triglyceride levels.

Product Details:

Composition
Glimpride 2 mg. & Metformin 500 mg. ( Bilayer).

•  Corrects defective insulin secretion & peripheral insulin resistance
•  Decreases fasting & pp plasma insulin & triglyceride levels

Product Details:

Glimepiride 1 mg Metformin 1000 mg SR Tablets

• Corrects defective insulin secretion & peripheral insulin resistance
• Decreases fasting & pp plasma insulin & triglyceride levels.

Product Details:

Sitagliptin

• Well tolerated & improved glycaemic control
• Oral sitagliptin as initial combination therapy with metformin or pioglitazone significantly improved glycaemic control in adult patients with inadequately controlled type 2 diabetes

Metformin

• Reduces the amount of glucose produced by the liver & preserves the function of the cells in the pancreas

Product Details:

Sitagliptin 50 Mg Tab

• Well tolerated & improved glycaemic control
• Oral sitagliptin as initial combination therapy with metformin or pioglitazone significantly improved glycaemic control in adult patients with inadequately controlled type 2 diabetes

Product Details:

Linagliptin 2.5 mg And Metformin 500mg Tablet

• Provide a valuable treatment option for individuals with inadequate glycaemic control
• Internationally approved & accepted

Product Details:

Dapaglifozin Tablets 10 mg.

• Exerts antihyperglycaemic, cardioprotective & renoprotective properties
• Reduces renal glucose reabsorption by increasing urinary glucose excertion & reducing blood glucose levels

Product Details:

Vildagliptin 100 mg  Tablets 

• Improves glucose control and significantly reduces GI adverse events.
• Improved glycemic control and was highly tolerable in T2DM patients

Product Details:

Composition:

• Corrects defective insulin secretion & peripheral insulin resistance
• Decreases fasting & pp plasma insulin & triglyceride levels

Product Details:

Teneligliptin Hydrobromide  20 mg Tablet.

Teneligliptin- A potent, selective and long-lasting DPP-4 inhibitor. Improved blood glucose levels.Significantly reduced the 24-h mean sensor glucose levels 

Product Details:

Glimepiride 1 mg Metformin 500 mg SR Voglibose 0.3 mg Tab

• Corrects defective insulin secretion & peripheral insulin resistance
• Decreases fasting & pp plasma insulin & triglyceride levels.

Product Details:

Glimepiride 2 mg Voglibose 0.3 mg Metformin 500 mg SR Tablets

• Corrects defective insulin secretion & peripheral insulin resistance
• Decreases fasting & pp plasma insulin & triglyceride levels.

Product Details:

Teneligliptin Hydrobromide  20 mg & Metformin Hydrochloride Sustained Release Tablet
Teneligliptin- A potent, selective and long-lasting DPP-4 inhibitor. Improved blood glucose levels.Significantly reduced the 24-h mean sensor glucose levels

Metformin-Increases peripheral insulin sensitivity reduces hepatic glucose production

Product Details:

Vildagliptin & Metformin Hydrochloride Tablets

Vildagliptin as add-on therapy to to Metformin

• Improves glucose control and significantly reduces GI adverse events.
• Vildagliptin does not cause weight gain in combination with Metformin
•